Table 2 Spearman correlations of risk factors associated with FF-FGF13 in PCOS and non-PCOS patients
PCOS | Non-PCOS | |||
|---|---|---|---|---|
r | P values | r | P values | |
Age (years) | −0.038 | 0.81 | 0.090 | 0.62 |
BMI (kg/m2) | 0.10 | 0.50 | 0.37 | 0.041 |
Increased ovarian volume (YES = 1, NO = 0) | 0.33 | 0.032 | 0.32 | 0.089 |
FF-LH (IU/L) | 0.035 | 0.83 | −0.0017 | 0.99 |
FF- FSH (IU/L) | −0.055 | 0.73 | 0.23 | 0.20 |
FF-TT (nmol/L) | 0.37 | 0.013 | 0.035 | 0.85 |
FF-FAI | 0.20 | 0.19 | 0.21 | 0.24 |
FF-E2 (μg/L) | 0.14 | 0.3 | −0.076 | 0.68 |
FF-P4 (mg/L) | −0.21 | 0.17 | −0.20 | 0.27 |
FF-IL-6 (pg/mL) | −0.025 | 0.88 | −0.036 | 0.85 |
FF-FGF21 (pg/mL) | 0.32 | 0.035 | 0.33 | 0.063 |